As of 2026-06-10, the Relative Valuation of Pharmala Biotech Holdings Inc (MDMA.CN) is - CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.14 CAD, the upside of Pharmala Biotech Holdings Inc based on Relative Valuation is -.
The range of the Relative Valuation is - CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | P/E |
| 2026-05-28 | -8.51 |
| 2026-05-27 | -8.25 |
| 2026-05-26 | -8.25 |
| 2026-05-25 | -9.02 |
| 2026-05-22 | -7.48 |
| 2026-05-21 | -8.25 |
| 2026-05-20 | -8.51 |
| 2026-05-19 | -7.74 |
| 2026-05-15 | -7.48 |
| 2026-05-14 | -7.99 |
| 2026-05-13 | -7.74 |
| 2026-05-12 | -7.22 |
| 2026-05-11 | -7.74 |
| 2026-05-08 | -7.74 |
| 2026-05-07 | -7.48 |
| 2026-05-06 | -7.74 |
| 2026-05-05 | -7.74 |
| 2026-05-04 | -7.99 |
| 2026-05-01 | -7.22 |
| 2026-04-30 | -7.22 |
| 2026-04-29 | -7.48 |
| 2026-04-28 | -8.25 |
| 2026-04-27 | -8.51 |
| 2026-04-24 | -7.48 |
| 2026-04-23 | -7.99 |
| 2026-04-22 | -8.25 |
| 2026-04-21 | -7.99 |
| 2026-04-20 | -9.28 |
| 2026-04-17 | -5.16 |
| 2026-04-16 | -5.16 |
| 2026-04-15 | -4.90 |
| 2026-04-14 | -5.16 |
| 2026-04-13 | -4.90 |
| 2026-04-10 | -5.16 |
| 2026-04-09 | -5.16 |
| 2026-04-08 | -5.16 |
| 2026-04-07 | -5.16 |
| 2026-04-06 | -5.41 |
| 2026-04-02 | -5.67 |
| 2026-04-01 | -5.41 |
| 2026-03-31 | -5.16 |
| 2026-03-30 | -5.41 |
| 2026-03-27 | -5.16 |
| 2026-03-26 | -5.41 |
| 2026-03-25 | -5.67 |
| 2026-03-24 | -5.67 |
| 2026-03-23 | -5.16 |
| 2026-03-20 | -5.16 |
| 2026-03-19 | -5.41 |
| 2026-03-18 | -5.93 |